Fundraising Fox

Acceleron

Cambridge, US · 7 known investors

acceleronpharma.com ↗

A pharmaceutical company that develops medicines and vaccines for patients globally.

BiotechHealthtechMedical Devices

Founders & leadership

SE
STEVEN ERTELNamed on SEC filing
RS
ROBERT STEININGERNamed on SEC filing
KF
KEVIN F. MCLAUGHLINNamed on SEC filing
RP
RICHARD POPSNamed on SEC filing
EM
EDWIN M. KANIANamed on SEC filing
CL
CARL L. GORDONNamed on SEC filing
JG
JEAN GEORGENamed on SEC filing
WW
WYLIE W. VALENamed on SEC filing
TG
TERRANCE G. MCGUIRENamed on SEC filing
JK
JOHN KNOPFNamed on SEC filing
AB
ANTHONY B EVNINNamed on SEC filing
ML
MATTHEW L. SHERMANNamed on SEC filing

Investors · 7

Bessemer Venture PartnersRedwood City · $5M – $100M
Foresite CapitalLarkspur
Lightstone VenturesPortola Valley
Lowercarbon CapitalNew York · $100K – $5M
Sofinnova VenturesMenlo Park · $100K – $15M
VenrockPalo Alto · $500K – $10M
Collaborative FundreportedNew York · $500K – $1M

Reported raises · per SEC filings

Form D private placements

$30.5M disclosed across 1 round · 2011

▶$30.5MraisedJan 2012 · 47 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • STEVEN ERTELExecutive Officer
  • ROBERT STEININGERExecutive Officer
  • KEVIN F. MCLAUGHLINExecutive Officer
  • RICHARD POPSDirector
  • EDWIN M. KANIADirector
  • CARL L. GORDONDirector
  • JEAN GEORGEDirector
  • WYLIE W. VALEDirector
  • TERRANCE G. MCGUIREDirector
  • JOHN KNOPFExecutive Officer, Director
  • ANTHONY B EVNINDirector
  • MATTHEW L. SHERMANExecutive Officer
  • JOSEPH S. ZAKRZEWSKIDirector
  • GEORGE GOLUMBESKIDirector
  • TOM MANIATISDirector
Offering amount
$30.5M
Amount sold
$30.5M
First sale
Dec 2011
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Acceleron Fusion raises $24M in seed funding to advance low-temp fusion -- ANS / Nuclear Newswireans.org · Dec 2024US firm's 'cool' plasma-free fusion technology gets funding boostinterestingengineering.com · Dec 2024Acceleron Secures $24M for its Muon-Catalyzed Fusion Reactortowardfusion.com · Dec 2024Acceleron Fusion Raises $15M for Cold Fusion Breakthroughtechnews180.com · Oct 2024Large Acceleron Stakeholder Says Acquisition Price Undervalues Company - BioSpacebiospace.com · Oct 2021Acceleron Raises $31 Million | PE Hubpehub.com · Oct 2007

Frequently asked questions

What does Acceleron do?
A pharmaceutical company that develops medicines and vaccines for patients globally.
Who are Acceleron's investors?
Acceleron's investors include Bessemer Venture Partners, Foresite Capital, Lightstone Ventures, Lowercarbon Capital, Sofinnova Ventures, Venrock, Collaborative Fund.
How much funding has Acceleron raised?
Acceleron has disclosed $30.5M raised across 1 round.
Where is Acceleron headquartered?
Acceleron is headquartered in Cambridge, US.